Skip to main content
File #: 12432   
Type: Consent Status: Passed
File created: 6/9/2025 Department: Arrowhead Regional Medical Center
On agenda: 6/18/2025 Final action: 6/18/2025
Subject: Amendment to Supply Agreement with Haemonetics Corporation for Reagents, Supplies, and Preventative Maintenance Services
Attachments: 1. CON - ARMC - 6-18-25 - Haemonetics Corp A-2 to 22-689, 2. Item #13 Executed Contract, 3. 22-689 A-2 Executed Contract
REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION

June 18, 2025

FROM
ANDREW GOLDFRACH, ARMC Chief Executive Officer, Arrowhead Regional Medical Center

SUBJECT
Title
Amendment to Supply Agreement with Haemonetics Corporation for Reagents, Supplies, and Preventative Maintenance Services
End

RECOMMENDATION(S)
Recommendation
Approve Amendment No. 2 to Supply Agreement No. 22-689 with Haemonetics, Corporation for reagents, supplies, and preventative maintenance services, increasing the not to exceed contract amount by $146,763, from $522,134 to $668,897, and extending the term of the Agreement by 12 months for a total contract period of July 12, 2022 through July 31, 2026.
(Presenter: Andrew Goldfrach, ARMC Chief Executive Officer, 580-6150)
Body

COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.

FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost). The cost of $146,763 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2024-25 budget and have been included in the 2025-26 recommended budget.

BACKGROUND INFORMATION
Approval of Amendment No. 2 (Amendment) to Agreement No. 22-689 (Agreement) with Haemonetics Corporation (Haemonetics) will allow ARMC to continue to purchase reagents, supplies, and receive service on two analyzers. The total increase in the agreement amount is based on the anticipated need for an additional 12 months.

Reagents are substances or mixtures that are used in the ARMC Laboratory for chemical analysis. Haemonetics will provide continuous r...

Click here for full text